Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
Enveric expects to file Investigational New Drug application for EB-003 in early 2026 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB)... Read more.
Conduent Integrates AI Technologies to Modernize Government Payments, Combat Fraud and Improve Customer Experiences for Beneficiaries
Successfully completed AI pilot with Microsoft – now live – boosts fraud detection FLORHAM PARK, N.J.–(BUSINESS WIRE)–Conduent Incorporated (Nasdaq:... Read more.
Vagaro partners with Affirm to offer a smarter, more flexible way to pay for wellness and beauty services
SAN FRANCISCO–(BUSINESS WIRE)–Vagaro, the leading software for businesses in beauty, wellness, and fitness, today announced a partnership with Affirm... Read more.
Aureon Expands Cloud Solutions with Ascend for Teams Powered by Intermedia Cloud Communications
Unified platform delivers advanced UCaaS and CCaaS capabilities to enhance business communications WEST DES MOINES, Iowa–(BUSINESS WIRE)–#Aureon—Aureon,... Read more.
AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+
A premier resource for NAD+ science—highlighting nicotinamide riboside (NR)—the newly evolved site features peer-reviewed studies, educational content, and a... Read more.
MEDITECH Advances Toward Agentic User Experience and Previews New AI Initiatives
Annual MEDITECH LIVE event to highlight latest AI solutions and customer successes CANTON, Mass.–(BUSINESS WIRE)–#Expanse–MEDITECH today announced... Read more.
MEDITECH Advances Toward Agentic User Experience and Previews New AI Initiatives
Annual MEDITECH LIVE event to highlight latest AI solutions and customer successes CANTON, Mass.–(BUSINESS WIRE)–#Expanse–MEDITECH today announced... Read more.
Marathon Asset Management Broadens Access to Its ABL Strategy on iCapital Marketplace
NEW YORK–(BUSINESS WIRE)–Marathon Asset Management (“Marathon”), a leading global asset manager specializing in private and public credit, today... Read more.
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-250 for Myeloid Malignancies
First-in-human CROSSCHECK-001 study marks company’s entry into the clinic with novel T-Bolt™ T-cell engager (TCE) CAMBRIDGE, Mass.–(BUSINESS WIRE)–Crossbow... Read more.
Peraton Joins Forces with Snowflake to Fight Federal and State Fraud, Waste, and Abuse with Rapid FI
Industry leaders collaborate for enhanced fraud detection to help agencies save American taxpayer dollars RESTON, Va.–(BUSINESS WIRE)–#FWA—Peraton,... Read more.